ORD 43914/2024

—·EP3666797: ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Verfahrensführungsanordnungen
Parteien: Kläger
Amgen Inc.
Vertreter: Johannes Heselberger
Beklagte
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Groupe S.A.
Sanofi Winthrop Industrie
Regeneron Pharmaceuticals Inc.
Vertreter: Niels Hölder
Division: Munich LD
Richter: Matthias Zigann · Presiding judge and judge-rapporteur
Tobias Pichlmaier · Legally qualified judge
Samuel Granata · Legally qualified judge
Xavier Dorland-Galliot · Technically qualified judge
Technology: Biotechnology
Sprache: —
Erste Entscheidung: 29. Juli 2024

Entscheidungen

2024-07-29
Generic Order
The Munich Local Division issued a procedural order concerning a stay of infringement proceedings in the Amgen v Sanofi/Regeneron case relating to EP3666797, in light of parallel EPO opposition proceedings and a separate revocation action filed by the defendants at the UPC Central Division.
Rechtsfragen:Stay of proceedings pending EPO oppositionParallel revocation action at UPC Central DivisionRelationship between infringement and revocation proceedings

Dokumente